George Clinical

George Clinical acquires Vector Oncology’s Pharma Services

Thursday, May 4, 2017

George Clinical, a full-service CRO in the Asia-Pacific region, and Vector Oncology, a Memphis-based leader in oncology research and data analytics, announced that George Clinical has acquired Vector Oncology’s Pharma Services (CRO) Division. Effective immediately, the transaction has the dual purpose of strengthening the ability of George Clinical to provide scientifically led oncology trial delivery solutions throughout the Asia-Pacific, and, more broadly, to expand George Clinical’s  operational expertise and scientific leadership in vascular, renal and respiratory diseases, neurology and endocrinology throughout the U.S.

[Read More]